ACADIA Pharmaceuticals Inc (ACAD) — Free Cash Flow Generation Index
ACADIA Pharmaceuticals Inc (ACAD) has a Free Cash Flow Generation Index of 0.92x as of June 2026. Free cash flow of $124.46 Million represents 1% of operating cash flow ($134.76 Million). Explore how much does ACADIA Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ACADIA Pharmaceuticals Inc Free Cash Flow Generation Index (2023–2025)
Historical FCF Generation Index trend for ACADIA Pharmaceuticals Inc across 3 annual periods. For the full cash flow conversion analysis, see ACADIA Pharmaceuticals Inc operating cash flow efficiency.
Annual Free Cash Flow Generation for ACADIA Pharmaceuticals Inc (2023–2025)
Year-by-year Free Cash Flow Generation Index for ACADIA Pharmaceuticals Inc. Check cash flow reinvestment rate of ACADIA Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | $105.15 Million | $109.84 Million | $4.69 Million | ▼ -4.0% |
| 2024 | 1.00x | $157.20 Million | $157.72 Million | $523.00K | ▲ +171.3% |
| 2023 | -1.40x | $-23.35 Million | $16.70 Million | $40.05 Million | — |